Anny Bedard

Anny Bedard is an accomplished executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a member of Chief and President North America at Egetis Therapeutics US since December 2022, Anny has held various leadership roles including President at ABio Consulting, where expertise in global commercialization for rare diseases was emphasized. Previous positions include Head of International Business at Sarepta Therapeutics and Vice President/General Manager for Shire Pharmaceuticals in Japan/Asia Pacific, where substantial expansion initiatives were successfully executed. Anny's earlier career includes significant contributions at EMD Serono and Fournier Pharma, complementing strong educational credentials with a Master's degree in Molecular and Cellular Biology and a Bachelor's degree in Biochemistry from Université Laval.